HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical spectrum and long-term outcome of Ebstein's anomaly based on a 26-year experience in an Asian cohort.

Abstract
Ebstein's anomaly is a rare, congenital cardiac anomaly that may result in cyanosis, right heart failure, and tachyarrhythmia during the newborn stage or after adolescence. This study investigated the data of 77 patients diagnosed between 1980 and 2006 at a tertiary care center in Taiwan. Patients were grouped into either an early group or a late group. Survival declined rapidly within the newborn stage in the early group, but declined only during the third decade in the late group. Surgical results were poor (20% success rate) for neonatal systemic-to-pulmonary shunts in those cases with associated pulmonary atresia, but were satisfactory for other surgical modes. Supraventricular tachyarrhythmia occurred in 31 (41%) patients at a median age of 10 years and could be eliminated by radiofrequency ablation (81% success rate), though the recurrence rate was high (41%). In conclusion, other than those cases requiring shunts at the newborn stage, the long-term outcome was favorable.
AuthorsYa-Mei Chang, Jou-Kou Wang, Sheunn-Nan Chiu, Ming-Tai Lin, En-Ting Wu, Chun-An Chen, Shu-Chien Huang, Yih-Sharng Chen, Chung-I Chang, Ing-Sh Chiu, Jiunn-Lee Lin, Ling-Ping Lai, Mei-Hwan Wu
JournalEuropean journal of pediatrics (Eur J Pediatr) Vol. 168 Issue 6 Pg. 685-90 (Jun 2009) ISSN: 1432-1076 [Electronic] Germany
PMID18781325 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Catheter Ablation
  • Child
  • Child, Preschool
  • Ebstein Anomaly (complications, diagnosis, mortality, surgery)
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Kaplan-Meier Estimate
  • Male
  • Retrospective Studies
  • Tachycardia, Supraventricular (etiology, therapy)
  • Taiwan
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: